iShares U.S. Medical Devices ETF

iShares U.S. Medical Devices ETF

IHI
iShares U.S. Medical Devices ETFUS flagNew York Stock Exchange Arca
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
iShares U.S. Medical Devices ETF (IHI) seeks to track the investment results of an index composed of U.S. equities in the medical devices sector, specifically the Dow Jones U.S. Select Medical Equipment Index, a market-cap-weighted benchmark of U.S. manufacturers and distributors of medical equipment. The ETF provides exposure to companies engaged in the development, manufacturing, and distribution of medical devices including diagnostic imaging equipment, surgical instruments, monitoring devices, orthopedics, cardiology products, and related healthcare technologies; top holdings as of recent data include Abbott Laboratories (ABT), Intuitive Surgical Inc. (ISRG), Boston Scientific Corp. (BSX), Medtronic plc (MDT), and Stryker Corp. (SYK). Managed by BlackRock with an expense ratio of 0.38%, IHI holds approximately 54 stocks, pays quarterly dividends, and trades on NYSE Arca. Launched on May 1, 2006, and headquartered in New York alongside its issuer BlackRock Inc., the ETF focuses primarily on the U.S. market, targeting institutional and retail investors seeking sector-specific healthcare exposure amid aging populations and technological advancements in medical devices. Geographically, operations center on U.S.-listed equities, with no significant international revenue diversification beyond the domestic focus of holdings. In recent developments, IHI has seen steady assets under management growth to around $4.25 billion, supported by quarterly dividend increases such as the September 2025 ex-dividend payout of $0.06088 per share; institutional holdings adjustments continue, including Creative Planning's 31.3% position increase to 40,034 shares in Q2 2025. BlackRock, the ETF's provider, pursued broader strategic expansions including the 2024 acquisition of Global Infrastructure Partners for $12.5 billion, alongside 2025 launches of new iShares ETFs like the Infrastructure Active ETF (BILT) and Total USD Fixed Income Market ETF (BTOT), though no direct changes to IHI's structure, index, or holdings methodology were reported in 2024-2025. The fund maintains its core passive strategy without noted reorganizations, partnerships, or product shifts specific to IHI.